← All indications
Altitude Sickness
Multiple symptoms associated with reduced oxygen at high ALTITUDE.
Drugs by status
Approved for this indication (2)
Phase 4 trials (14)
Phase 3 trials (9)
Phase 2 trials (5)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (23)
- Bayer
- Altitude Physiology Expeditions
- United States Army
- Duke University
- Istituto Auxologico Italiano
- Mountain Medicine Society of Nepal
- Cayetano Heredia University
- University of Edinburgh
- University of Zurich
- Association pour la Recherche en Physiologie de l'Environnement
- University of British Columbia
- University of Colorado, Denver
- University of Ulsan
- University of Utah
- CJ HealthCare Corp.
- University of Oxford
- University of Massachusetts
- Wellcome Trust
- University of Paris
- University of Colorado
- Alma College
- Legs Poix
- Government of Kyrgyzstan
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (16)
- Bangor University
- Centre d’Expertise sur l’Altitude EXALT
- Harvard University
- Hospital del Trabajador de Santiago
- Northumbria University
- University of Lausanne
- University of Reading
- University of Toronto
- Tel Aviv University
- Free University of Brussels
- Instituto Boliviano de Biologia de Altura
- Universitad Major de S. Andres, La Paz, Bolivia
- Government of United Kingdom
- Centura Health
- Pulmodyne, Inc.
- Himalayan Rescue Association